FUS immunoreactivity of neuronal and glial intranuclear inclusions in intranuclear inclusion body disease

Neuropathology and Applied Neurobiology

Volumn 38, Issue 4, 2012, Pages 322-328

  Mori, F ^a   Tanji, K ^a   Kon, T ^a   Odagiri, S ^a,b   Hattori, M ^c   Hoshikawa, Y ^c   Kono, C ^d   Yasui, K ^e   Yokoi, S ^e   Hasegawa, Y ^e   Yoshida, M ^f   Wakabayashi, K ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

^c NAGOYA CITY UNIVERSITY   (Japan)

^d Yagoto Hospital   (Japan)

^e NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^f AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

FUS; Glial cell; Intranuclear inclusion body disease; TLS

Indexed keywords

FUSED IN SARCOMA PROTEIN;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; AUTOPSY; BRAIN; CELL NUCLEUS INCLUSION BODY; CLINICAL ARTICLE; CYTOPLASM; FEMALE; GANGLION; GLIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRANUCLEAR INCLUSION BODY DISEASE; NERVE CELL; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD;

AGED; BRAIN; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRANUCLEAR INCLUSION BODIES; MIDDLE AGED; NEURODEGENERATIVE DISEASES; NEUROGLIA; NEURONS; RNA-BINDING PROTEIN FUS; SPINAL CORD;

EID: 84860901797     PISSN: 03051846     EISSN: 13652990     Source Type: Journal    
DOI: 10.1111/j.1365-2990.2011.01217.x     Document Type: Article

References (27)

1. Lindenberg R, Rubinstein LJ, Herman MM, Haydon GB. A light and electron microscopy study of an unusual widespread nuclear inclusion body disease. A possible residuum of an old herpesvirus infection. Acta Neuropathol 1968; 10: 54-73.
2. Soffer D. Neuronal intranuclear hyaline inclusion disease presenting as Friedreich's ataxia. Acta Neuropathol 1985; 65: 322-9.
3. Takahashi-Fujigasaki J. Neuronal intranuclear hyaline inclusion disease. Neuropathology 2003; 23: 351-9.
4. Sone J, Hishikawa N, Koike H, Hattori N, Hirayama M, Nagamatsu M, Yamamoto M, Tanaka F, Yoshida M, Hashizume Y, Imamura H, Yamada E, Sobue G. Neuronal intranuclear hyaline inclusion disease showing motor-sensory and autonomic neuropathy. Neurology 2005; 65: 1538-43.
5. Weidenheim KM, Dickson DW. Intranuclear inclusion bodies in an elderly demented woman: a form of intranuclear inclusion body disease. Clin Neuropathol 1995; 14: 93-9.
6. Munoz-Garcia D, Ludwin SK. Adult-onset neuronal intranuclear hyaline inclusion disease. Neurology 1986; 36: 785-90.
7. Zannolli R, Gilman S, Rossi S, Volpi N, Bernini A, Galluzzi P, Galimberti D, Pucci L, D'Ambrosio A, Morgese G, Giannini F. Hereditary neuronal intranuclear inclusion disease with autonomic failure and cerebellar degeneration. Arch Neurol 2002; 59: 1319-26.
8. Liu Y, Mimuro M, Yoshida M, Hashizume Y, Niwa H, Miyao S, Ujihira N, Akatsu H. Inclusion-positive cell types in adult-onset intranuclear inclusion body disease: implications for clinical diagnosis. Acta Neuropathol 2008; 116: 615-23.
9. Mori F, Miki Y, Tanji K, Ogura E, Yagihashi N, Jensen PH, Wakabayashi K. Incipient intranuclear inclusion body disease in a 78-year-old woman. Neuropathology 2011; 31: 188-93.
10. Aman P, Panagopoulos I, Lassen C, Fioretos T, Mencinger M, Toresson H, Hoglund M, Forster A, Rabbitts TH, Ron D, Mandahl N, Mitelman F. Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics 1996; 37: 1-8.
11. Andersson MK, Stahlberg A, Arvidsson Y, Olofsson A, Semb H, Stenman G, Nilsson O, Aman P. The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biol 2008; 9: 37.
12. Crozat A, Aman P, Mandahl N, Ron D. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 1993; 363: 640-4.
13. Zinszner H, Sok J, Immanuel D, Yin Y, Ron D. TLS (FUS) binds RNA in vivo and engages in nucleo-cytoplasmic shuttling. J Cell Sci 1997; 110 (Pt 15): 1741-50.
14. Perrotti D, Bonatti S, Trotta R, Martinez R, Skorski T, Salomoni P, Grassilli E, Lozzo RV, Cooper DR, Calabretta B. TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis. EMBO J 1998; 17: 4442-55.
15. Bertrand P, Akhmedov AT, Delacote F, Durrbach A, Lopez BS. Human POMp75 is identified as the pro-oncoprotein TLS/FUS: both POMp75 and POMp100 DNA homologous pairing activities are associated to cell proliferation. Oncogene 1999; 18: 4515-21.
16. Baechtold H, Kuroda M, Sok J, Ron D, Lopez BS, Akhmedov AT. Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein TLS/FUS and is able to promote d-loop formation. J Biol Chem 1999; 274: 34337-42.
17. Yang L, Embree LJ, Tsai S, Hickstein DD. Oncoprotein TLS interacts with serine-arginine proteins involved in RNA splicing. J Biol Chem 1998; 273: 27761-4.
18. Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, Ganesalingam J, Williams KL, Tripathi V, Al-Saraj S, Al-Chalabi A, Leigh PN, Blair IP, Nicholson G, de Belleroche J, Gallo JM, Miller CC, Shaw CE. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009; 323: 1208-11.
19. Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, Valdmanis P, Rouleau GA, Hosler BA, Cortelli P, de Jong PJ, Yoshinaga Y, Haines JL, Pericak-Vance MA, Yan J, Ticozzi N, Siddique T, McKenna-Yasek D, Sapp PC, Horvitz HR, Landers JE, Brown RH Jr. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009; 323: 1205-8.
20. Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, Kovacs GG, Ghetti B, Halliday G, Holm IE, Ince PG, Kamphorst W, Revesz T, Rozemuller AJ, Kumar-Singh S, Akiyama H, Baborie A, Spina S, Dickson DW, Trojanowski JQ, Mann DM. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol 2010; 119: 1-4.
21. Woulfe J, Gray DA, Mackenzie IR. FUS-immunoreactive intranuclear inclusions in neurodegenerative disease. Brain Pathol 2010; 20: 589-97.
22. Mori F, Tanji K, Kakita A, Takahashi H, Wakabayashi K. Enhancement of native and phosphorylated TDP-43 immunoreactivity by proteinase K treatment following autoclave heating. Neuropathology 2011; 31: 401-4.
23. Takahashi-Fujigasaki J, Arai K, Funata N, Fujigasaki H. SUMOylation substrates in neuronal intranuclear inclusion disease. Neuropathol Appl Neurobiol 2006; 32: 92-100.
24. Meltzer JC, Grimm PC, Greenberg AH, Nance DM. Enhanced immunohistochemical detection of autonomic nerve fibers, cytokines and inducible nitric oxide synthase by light and fluorescent microscopy in rat spleen. J Histochem Cytochem 1997; 45: 599-610.
25. Ebeling W, Hennrich N, Klockow M, Metz H, Orth HD, Lang H. Proteinase K from Tritirachium album Limber. Eur J Biochem 1974; 47: 91-7.
26. Fujii R, Takumi T. TLS facilitates transport of mRNA encoding an actin-stabilizing protein to dendritic spines. J Cell Sci 2005; 118: 5755-65.
27. Fujii R, Okabe S, Urushido T, Inoue K, Yoshimura A, Tachibana T, Nishikawa T, Hicks GG, Takumi T. The RNA binding protein TLS is translocated to dendritic spines by mGluR5 activation and regulates spine morphology. Curr Biol 2005; 15: 587-93.